Grünenthal Group
Gunther Pauwels is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the RTX Inspection Readiness Lead for Grünenthal Group since September 2023, focusing on dossier submissions and pre-approval inspections for the RTX product. As the founder of Provalion since November 2017, Gunther Pauwels has emphasized professional value creation in the (bio)pharma industry. Previous roles include Head of pDNA Production at Catalent PS, Director of Corporate Quality at Eurofins CDMO, and Vice President & General Manager at Sanofi Genzyme, among others. Gunther Pauwels began the career as a trainee Industrial Pharmacist at Welcome Foundation Ltd in 1995, having completed studies at Ghent University from 1989 to 1995.
This person is not in any teams
This person is not in any offices
Grünenthal Group
5 followers
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.